Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Capital Expenditures (2024)

Fennec Pharmaceuticals' Capital Expenditures history spans 4 years, with the latest figure at $1.7 million for Q1 2024.

  • For the quarter ending Q1 2024, Capital Expenditures changed N/A year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Jun 2024, changed N/A, and an annual FY2022 reading of $175000.0, changed N/A over the prior year.
  • Capital Expenditures for Q1 2024 was $1.7 million at Fennec Pharmaceuticals, up from $1.4 million in the prior quarter.
  • The five-year high for Capital Expenditures was $1.7 million in Q1 2024, with the low at $1.7 million in Q1 2024.